Immune effector cells in SpA: What are the pathways?
Egile Nagusiak: | , , , , , , , , |
---|---|
Formatua: | Conference item |
Argitaratua: |
Clinical and Experimental Rheumatology
2018
|
Egile Nagusiak: | , , , , , , , , |
---|---|
Formatua: | Conference item |
Argitaratua: |
Clinical and Experimental Rheumatology
2018
|